MedTrace Logo

Lung Function After Robot-assisted Radical Prostate Ectomy

NCT02066246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2014-10-09

No results posted yet for this study

Summary

The aim of our study is to investigate if the use of the AirSeal insufflation system impairs the lung function of patients less than a conventional system in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Therefore we examine the lung function before and after surgery.

As a second purpose of the study, in a subgroup, we investigate the influence of the gas insufflators (AirSeal and conventional) on hemodynamics during surgery. Furthermore we study the change in the lung perfusion-ventilation-ratio by using the electric impedance tomography technique.

Conditions

  • Lung Function

Interventions

DEVICE

AirSeal

100 patients are treated with the AirSeal insufflation and trocar system

DEVICE

Olympus UHI-3

100 patients are treated with a conventional insufflation and trocar system

Sponsors & Collaborators

  • Prostate Center North West Department of Urology and Pediatric Urology

    collaborator UNKNOWN

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Daniel A Reuter, PhD MD · Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg

  • Alexander März, MD · Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg

  • Günter Lippert, MD · Prostate Cancer Center North West, at St. Antonius-Hospital, Gronau, Germany .

  • Alexander Haese, PhD MD · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

  • Jörn Witt, MD · Prostate Cancer Center North West, at St. Antonius-Hospital, Gronau, Germany

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02066246 on ClinicalTrials.gov